glp-1 anesthesia guidelines 2025 The 2023 ASA position on receptor agonists has been overturned by three consensus statements. Continue the drug. Change the fast. ANZCA/ADS/GESA/NACOS, the Association of Anaesthetists/RCoA, and SPAQI/AACE now converge on Indications for GLP-1/GIP RA Summary
Description
It is generally used as a short-term treatment, although some people take it for longer periods if recommended by a healthcare provider

In rare cases, this can increase the risk of regurgitation and aspirationstomach contents going into the lungswhich can lead to pneumonia, prolonged hospital stay, or even intensive care

Serious adverse events occurred at comparable rates to placebo in Phase 2 trials (4% in both arms)
[1] [4] This reduces the risk of hypoglycaemia compared to some other diabetes medications, though this risk increases when combined with insulin or sulfonylureas

Focus on fiber-rich carbohydrates, lean proteins, and limited added sugars

Stay hydrated by drinking in slow sips throughout the day
